Featured Research

from universities, journals, and other organizations

Wake Forest First To Apply Innovative Brain Cancer Treatment

Date:
July 26, 1999
Source:
Wake Forest University Baptist Medical Center
Summary:
Wake Forest University Baptist Medical Center recently became the first medical center to use an innovative treatment system for brain cancer known as the GliaSite Radiation Therapy System (RTS).

WINSTON-SALEM, N.C. -- Wake Forest University Baptist Medical Center recently became the first medical center to use an innovative treatment system for brain cancer known as the GliaSite Radiation Therapy System (RTS).

The Medical Center is one of five National Cancer Institute (NCI)-affiliated facilities conducting clinical trials of the investigational device. Developed by Proxima Therapeutics, the GliaSite RTS places a high dose of radiation directly into the tissue most likely to contain residual cancer cells following tumor removal.

The device is implanted during the same surgical procedure conducted to remove the tumor and is later filled with a liquid radiation source. Both are removed within several weeks, completing the treatment.

According to Stephen B. Tatter, M.D., Ph.D., attending neurosurgeon at the Medical Center, radiation is the most effective treatment for many malignant brain tumors. However, current technology prevents doctors from delivering high enough doses to stop many tumors from recurring. Tatter is principal investigator of the clinical trials at the Medical Center and national chairman for the study.

"Implanting radiation directly into the tumor, or brachytherapy, is the most promising technique to accomplish this," said Tatter. "Unfortunately, previous attempts at brachytherapy were extremely inconvenient for patients, and had a high rate of complications such as infection and the need for another operation. The Proxima GliaSite RTS is an investigational device designed to address these issues, making brachytherapy more convenient and safe."

The American Cancer Society projects 18,000 Americans will be diagnosed this year with malignant brain tumors. Nearly all experience tumor regrowth after initial treatment.

Studies indicate survival for patients with recurrent malignant brain tumors is approximately three months without therapeutic measures, five months with surgery alone, eight months with surgery and chemotherapy and 15 months with surgery and internal radiation.

Clinical trials evaluating the patented cancer treatment system are being conducted under the guidance of the NCI's New Approaches to Brain Tumor Therapy program. Other medical centers testing the device are: Johns Hopkins University School of Medicine, Baltimore; Emory University School of Medicine, Atlanta; Henry Ford Hospital, Detroit; and, University of Texas Health Science Center at San Antonio.


Story Source:

The above story is based on materials provided by Wake Forest University Baptist Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Wake Forest University Baptist Medical Center. "Wake Forest First To Apply Innovative Brain Cancer Treatment." ScienceDaily. ScienceDaily, 26 July 1999. <www.sciencedaily.com/releases/1999/07/990726071402.htm>.
Wake Forest University Baptist Medical Center. (1999, July 26). Wake Forest First To Apply Innovative Brain Cancer Treatment. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/1999/07/990726071402.htm
Wake Forest University Baptist Medical Center. "Wake Forest First To Apply Innovative Brain Cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/1999/07/990726071402.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins